These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5402966)

  • 21. [The use of vitamin B 15 in obliterative atherosclerosis of the lower lumbs].
    Afanas'eva LM
    Khirurgiia (Mosk); 1967 Dec; 43(12):36-8. PubMed ID: 5613253
    [No Abstract]   [Full Text] [Related]  

  • 22. [Venous hemodynamics in chronic occlusive diseases of arteries of the lower extremities].
    Koshkin VM; Rozofarov LM; Zaĭtseva LA; Karalkin AV; Saitova GD
    Klin Khir (1962); 1990; (7):18-20. PubMed ID: 2232525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An assessment of the efficacy of intravenous monotherapy with the preparation solcoseryl in patients with arteriosclerosis obliterans of the vessels of the lower extremities].
    Luk'ianov IuV; Shlomin VV; Sokurenko GIu; Didenko IuP; Orlov NN; Kondrat'ev VM; Batalin IV
    Vestn Khir Im I I Grek; 2000; 159(3):81-4. PubMed ID: 10983350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nerve conduction in upper extremity in obliterative atherosclerosis].
    Samusik J
    Wiad Lek; 1978 Jan; 31(1):33-7. PubMed ID: 654255
    [No Abstract]   [Full Text] [Related]  

  • 25. [Myocardial contraction and heart weight in patients with arteriosclerosis obliterans of the abdominal aorta before and after reconstructive surgery].
    Pokrovskiĭ AV; Krakovskiĭ IA; Ashurov BM; Krestinskaia NN
    Ter Arkh; 1982; 54(3):74-8. PubMed ID: 6211794
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapeutic effects of nitrendipine (Bayotensin) in patients with arteriosclerosis obliterans of lower limbs.
    Grodzińska L; Basista M; Ohlrogge R
    Prog Clin Biol Res; 1989; 301():423-7. PubMed ID: 2678132
    [No Abstract]   [Full Text] [Related]  

  • 27. Obliterative arteriosclerosis of extremities in patients with coronary heart disease.
    Lukasik E; Liszewska-Pfejfer D
    Cor Vasa; 1977; 19(3):176-83. PubMed ID: 923254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography].
    Motomiya T
    Nihon Naika Gakkai Zasshi; 1970 Feb; 59(2):117-25. PubMed ID: 4910199
    [No Abstract]   [Full Text] [Related]  

  • 29. L-arginine--substrate for no synthesis--its beneficial effects in therapy of patients with peripheral arterial disease: comparison with placebo-preliminary results.
    Slawinski M; Grodzinska L; Kostka-Trabka E; Bieron K; Goszcz A; Gryglewski RJ
    Acta Physiol Hung; 1996; 84(4):457-8. PubMed ID: 9328630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Central and peripheral circulation in arteriosclerosis obliterans of the lower extremities before and after surgical treatment].
    Barinov VS; Shcherbina NG
    Vestn Khir Im I I Grek; 1982 Jun; 128(6):58-62. PubMed ID: 7123769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of principal risk factors, hemorheological and blood coagulation characteristics in arteriosclerosis obliterans in the elderly].
    Battigelli D; Benedetti A; Calabrese S; Giansante C
    Ric Clin Lab; 1985; 15 Suppl 1():205-12. PubMed ID: 4035215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of long-term training in obliterative arteriopathy].
    Weidinger P; Uhlir H
    Med Welt; 1975 Nov; 26(48):2178-9. PubMed ID: 813084
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of hydroxyethylrutoside and its combination with acetylsalicylic acid in patients with obliterative atherosclerosis.
    Roztocil K; Oliva I; Prerovský I; Linhart J
    Cor Vasa; 1989; 31(2):128-33. PubMed ID: 2663343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of bamethan on blood flow in the lower extremity muscles of patients with obliterative arteriosclerosis].
    Polakowski P; Ciborska H; Soltysiak A; Berner J; Nowak-Wiaderek W
    Wiad Lek; 1972 Dec; 25(24):2199-205. PubMed ID: 4405061
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pathophysiological aspects of peripheral hemodynamics in thrombotic obliterating diseases of the legs].
    Sidarenko LN; Kazakov IuI
    Klin Khir (1962); 1981 Jul; (7):20-3. PubMed ID: 7277982
    [No Abstract]   [Full Text] [Related]  

  • 36. [The physiological aspects of the efficacy of reconstructive operations in arteriosclerosis obliterans of the lower extremities].
    Prokhorov GG; Sazonov AB; Skorodumov IuA; Ogneva NS; Keerig IuIu
    Vestn Khir Im I I Grek; 1992 Apr; 148(4):78-83. PubMed ID: 1302937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The use of gravitation overloading in the treatment of obliterative atherosclerosis of lower extremity arteries].
    Galkin RA; Kotel'nikov GP; Makarov IV; Oparin AN
    Vestn Khir Im I I Grek; 2003; 162(1):82-5. PubMed ID: 12708401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of prostaglandin E1 in chronic obliterative diseases of peripheral arteries].
    Zhang GS
    Zhonghua Wai Ke Za Zhi; 1988 Sep; 26(9):541-2, 573. PubMed ID: 3243146
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pulmonary hemodynamics in obliterating arterial diseases of the lower extremities].
    Silaev IuS; Kaska AV
    Klin Med (Mosk); 1978 Nov; 56(11):91-3. PubMed ID: 723205
    [No Abstract]   [Full Text] [Related]  

  • 40. [Intra-arterial infusion in treatment of obliterating atherosclerosis of the lower extremities].
    Lutsenko SM; Pisarenko AS
    Klin Khir (1962); 1977 Sep; (9):63-6. PubMed ID: 916516
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.